1. Home
  2. OMCC vs LEXX Comparison

OMCC vs LEXX Comparison

Compare OMCC & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMCC
  • LEXX
  • Stock Information
  • Founded
  • OMCC 1985
  • LEXX 2004
  • Country
  • OMCC United States
  • LEXX Canada
  • Employees
  • OMCC N/A
  • LEXX N/A
  • Industry
  • OMCC
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OMCC
  • LEXX Health Care
  • Exchange
  • OMCC NYSE
  • LEXX Nasdaq
  • Market Cap
  • OMCC 40.0M
  • LEXX 39.1M
  • IPO Year
  • OMCC N/A
  • LEXX N/A
  • Fundamental
  • Price
  • OMCC $6.45
  • LEXX $1.98
  • Analyst Decision
  • OMCC
  • LEXX Strong Buy
  • Analyst Count
  • OMCC 0
  • LEXX 2
  • Target Price
  • OMCC N/A
  • LEXX $11.00
  • AVG Volume (30 Days)
  • OMCC 6.9K
  • LEXX 246.8K
  • Earning Date
  • OMCC 02-11-2025
  • LEXX 01-10-2025
  • Dividend Yield
  • OMCC N/A
  • LEXX N/A
  • EPS Growth
  • OMCC N/A
  • LEXX N/A
  • EPS
  • OMCC N/A
  • LEXX N/A
  • Revenue
  • OMCC $22,181,000.00
  • LEXX $496,923.00
  • Revenue This Year
  • OMCC N/A
  • LEXX $20.39
  • Revenue Next Year
  • OMCC N/A
  • LEXX $113.25
  • P/E Ratio
  • OMCC N/A
  • LEXX N/A
  • Revenue Growth
  • OMCC N/A
  • LEXX 77.63
  • 52 Week Low
  • OMCC $5.29
  • LEXX $1.36
  • 52 Week High
  • OMCC $7.55
  • LEXX $6.85
  • Technical
  • Relative Strength Index (RSI)
  • OMCC N/A
  • LEXX 42.16
  • Support Level
  • OMCC N/A
  • LEXX $1.62
  • Resistance Level
  • OMCC N/A
  • LEXX $2.04
  • Average True Range (ATR)
  • OMCC 0.00
  • LEXX 0.23
  • MACD
  • OMCC 0.00
  • LEXX -0.02
  • Stochastic Oscillator
  • OMCC 0.00
  • LEXX 44.44

About OMCC OLD MARKET CAPITAL CORPORATION

Old Market Capital Corp formerly Nicholas Financial Inc is a specialized consumer finance company. It is engaged in acquiring and servicing automobile finance installment contracts for purchases of used and new automobiles and light trucks. It also originates direct consumer loans and sells consumer-finance-related products. The majority of its revenue comes from Interest and fee income.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: